Itamar Medical (www.itamar-medical.com) is a medical device company founded in 1997 by a group of renowned cardiologists and sleep experts. The company focuses on leading the integration of Sleep Apnea management into the cardiac patient care pathway.

The corporate headquarters, R&D, and manufacturing for Itamar Medical Ltd. are located in Israel.  The company markets, services and supports its products worldwide. Itamar Medical has wholly-owned subsidiaries in the U.S. and Japan and distribution channels around the world.

Their core strategies include

(i) the development, manufacturing and sales of the WatchPAT™ diagnostic product line based on the proprietary PAT® signal that was proven as a simple, comprehensive, reliable and scalable alternative to airflow and it enables point-of-deployment versatility; and

(ii) Total Sleep Solution – a product that includes a field support organization, partnerships, as well as core and supporting technologies that enable all physicians in general and Cardiologists in particular to provide a seamless and full continuum of care to Sleep Apnea patients as part of their care pathway.

In addition, the company has developed and is currently marketing the EndoPAT™ system – an

endothelial function assessment tool for risk classification used by clinicians, researchers and pharma companies to easily and reliably quantify and track arterial health.

Their solution is very high-performance and can bring a new level of quality to the existing products

For further queries, contact:

Tejinder Singh,

Trade Officer,

Israel Embassy, New Delhi

Tel: +91-11-30414546,

Email: Tejinder.Singh@israeltrade.gov.il